InsidersTradesSigma
Explore the full record of transactions filed by David Liberg, Membre du Conseil. Director active across 2 companies, notably Cantargia AB. Aggregated, 3 filings have been logged. Activity tracked since 29 August 2025. The latest transaction was disclosed on 30 March 2026 (Purchase). Regulator: FIN-FSA. All data is free.
3 of 3 declarations
David Liberg is a board member of Cantargia AB. He contributes to the strategic direction of the company, which focuses on developing innovative treatments for cancer. His experience in biotechnology and commitment to innovation are valuable assets for the company.